Αρχειοθήκη ιστολογίου

Κυριακή 13 Δεκεμβρίου 2020

A Phase 1 study of RO6870810, a novel bromodomain and extra-terminal protein inhibitor, in patients with NUT carcinoma, other solid tumours, or diffuse large B-cell lymphoma

a.sfakia shared this article with you from Inoreader
Via Cancer

41416_2020_1180_Fig1_HTML.png

British Journal of Cancer, Published online: 14 December 2020; doi:10.1038/s41416-020-01180-1

A Phase 1 study of RO6870810, a novel bromodomain and extra-terminal protein inhibitor, in patients with NUT carcinoma, other solid tumours, or diffuse large B-cell lymphoma
View on the web
στις

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,

Εγγραφή σε: Σχόλια ανάρτησης (Atom)

Αναζήτηση αυτού του ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader

Φόρτωση...